TMS Co (TSE:4891) Capex-to-Operating-Income : 0.00 (As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is TMS Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

TMS Co's Capital Expenditure for the three months ended in Nov. 2023 was 円0.00 Mil. Its Operating Income for the three months ended in Nov. 2023 was 円-221.40 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

TMS Co Capex-to-Operating-Income Historical Data

The historical data trend for TMS Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMS Co Capex-to-Operating-Income Chart

TMS Co Annual Data

Trend

Feb21

Feb22

Feb23

Capex-to-Operating-Income

0.01

TMS Co Quarterly Data
	Feb21	Feb22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Capex-to-Operating-Income	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of TMS Co's Capex-to-Operating-Income

For the Biotechnology subindustry, TMS Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TMS Co's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TMS Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where TMS Co's Capex-to-Operating-Income falls into.

TMS Co Capex-to-Operating-Income Calculation

TMS Co's Capex-to-Operating-Income for the fiscal year that ended in Feb. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-13.721)	/	-520.149
	=	N/A

TMS Co's Capex-to-Operating-Income for the quarter that ended in Nov. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	-221.398
	=	N/A

TMS Co (TSE:4891) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

TMS Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of TMS Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

TMS Co (TSE:4891) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TMS Co Ltd (TSE:4891) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-9 Fuchu-cho, Fuchu-shi, Keio Fuchu 1-chome building 11th floor, Tokyo, JPN, 183-0055

Website

https://www.tms-japan.co.jp

TMS Co Ltd is engaged in the research and development of pharmaceuticals, quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables.

TMS Co (TSE:4891) Headlines

No Headlines